Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine-Reference-Cited by-同舟云学术

Antibody persistence four years after primary immunization of infants and toddlers with Haemophilus influenzae type b CRM197 conjugate vaccine

Published:1991-10 Issue:4 Volume:119 Page:655-657
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Rothstein Edward P.,Madore Dace V.,Long Sarah S.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference8 articles.

1. Food and Drug Administration approval of use of a Haemophilus b conjugate vaccine for infants;Centers for Disease Control;MMWR,1990

2. Food and Drug Administration approval of use of Haemophilus b conjugate vaccine in infants;Centers for Disease Control;MMWR,1990

3. Decline in Haemophilus influenzae type b meningitis—Seattle-King County, Washington, 1984–1989;Boase;MMWR,1990

4. Safety and immunologic response to Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in 1- to 6-month old infants;Madore;Pediatrics,1990

5. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months;Madore;Pediatrics,1990

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An economic analysis of alternatives for childhood immunisation against Haemophilus influenzae type b disease;Australian Journal of Public Health;2010-02-12

2. Successful Induction of Protective Antibody Responses againstHaemophilus influenzaeType b and Diphtheria after Transcutaneous Immunization with the Glycoconjugate Polyribosyl Ribitol Phosphate–Cross‐Reacting Material197Vaccine;The Journal of Infectious Diseases;2004-09-15

3. Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant;Vaccine;2004-03

4. A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM197) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery;Vaccine;2000-12

5. Correlation of Clinical Parameters and Immunological Function with Human Immunodeficiency Virus Plasma Viremia in Children;Viral Immunology;1999-01